The study of endocrine cancers and oncology focuses on tumors affecting hormone-producing glands such as the thyroid, pancreas, and adrenal glands. Malignancies like pancreatic neuroendocrine tumors and medullary thyroid carcinoma require specialized treatment approaches due to their complex interaction with hormonal regulation. Advances in molecular oncology have led to targeted therapies that inhibit abnormal signaling pathways, improving survival rates. Immunotherapy is also gaining traction as a promising approach for endocrine cancers, particularly in cases resistant to traditional chemotherapy. Early detection through biomarker screening and imaging technologies enhances treatment efficacy. Ongoing research continues to refine therapeutic options, providing hope for improved patient outcomes.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti